Status:
NOT_YET_RECRUITING
Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study
Lead Sponsor:
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions:
Percutaneous Left Atrial Appendage Occlusion (LAAO)
Device-related Thrombus (DRT)
Eligibility:
All Genders
18+ years
Brief Summary
This study is a prospective, multicenter international trial aimed at assessing the actual incidence, identifying associated factors, and evaluating the clinical consequences of both persistent and re...
Detailed Description
BACKGROUND: Percutaneous left atrial appendage occlusion (LAAO) has emerged as a nonpharmacological alternative for stroke prevention in patients with non-valvular atrial fibrillation ineligible for c...
Eligibility Criteria
Inclusion
- Patients with diagnosis of probable/definite DRT after LAAO detected by transesophageal echocardiography (TEE) or cardiac computed tomography (CT).
- Age≥18 years old.
Exclusion
- Unable to provide informed consent
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06177704
Start Date
August 1 2024
End Date
January 1 2028
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCPQ-UL
Québec, Quebec, Canada, G1V 4G5